NCT06549920Active, not recruiting
Danish Breast Cancer Group Internal Mammary Node Study
Source: ClinicalTrials.gov · Last updated 12 Aug 2024
Brief summary (registry, in English)
The DBCG IMN study is a nationwide prospective population-based cohort study allocating node-positive breast cancer patients with right-sided tumors to internal mammary node irradiation (IMNI) and patients with left-sided tumors to no IMNI.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 7630 (actual)
- First submitted
- 8 Aug 2024
- Start date
- 1 Jan 2003
- Primary completion date
- 17 Nov 2023
- Lead sponsor
- Danish Breast Cancer Cooperative Group
- Diseases
- Childhood cancers
- NCT number
- NCT06549920
What you commit to
- Study type: Interventional
- Participants enrolled: 7630
- From 1 Jan 2003 to the primary completion date, 17 Nov 2023
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Prior malignancies, bilateral breast cancer, neoadjuvant systemic therapy, recurrence before radiotherapy, and non-standard radiotherapy.
Who the study is looking for
- Patients with macrometastatic node-positive breast cancer treated with loco-regional radiotherapy.
Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.